Showing 141 - 160 results of 198 for search '"Hengyang"', query time: 0.04s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145

    Risk Prediction of Liver Injury in Pediatric Tuberculosis Treatment: Development of an Automated Machine Learning Model by Zeng Y, Lu H, Li S, Shi QZ, Liu L, Gong YQ, Yan P

    Published 2025-01-01
    “…Ying Zeng,1,* Hong Lu,1,* Sen Li,2,* Qun-Zhi Shi,1 Lin Liu,1 Yong-Qing Gong,1 Pan Yan1 1Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, People’s Republic of China; 2Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China*These authors contributed equally to this workCorrespondence: Pan Yan, Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, People’s Republic of China, Email 2022050025@usc.edu.cnPurpose: Drug-induced liver injury (DILI) is one of the most common and serious adverse drug reactions related to first-line anti-tuberculosis drugs in pediatric tuberculosis patients. …”
    Get full text
    Article
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160